| Health / Medical Topics |
Relapse from Complete Response of Multiple Myeloma or Plasma Cell Leukemia
Relapse from complete response of multiple myeloma or plasma cell leukemia requires one or more of the following: reappearance of serum or urine M-protein by immunofixation or electrophoresis; development of 5% or more plasma cells in the bone marrow (relapse from complete response has a 5% cutoff vs.10% for other categories of relapse); appearance of any other sign of progression (e.g., new plasmacytoma, lytic bone lesion, hypercalcemia). Relapse requires two consecutive assessments made at any time before classification as relapse, and/or the institution of any new therapy. (NCI Thesaurus)
YOU MAY ALSO LIKE
The return of a disease or the signs and symptoms of a disease after a period of improvement. Relapse also refers to…
To affix a new label onto an item.
RelA-associated inhibitor (828 aa, ~89 kDa) is encoded by the human PPP1R13L gene. This protein is involved in the modulation of cellular…
Human RELA wild-type allele is located in the vicinity of 11q13 and is approximately 9 kb in length. This allele, which encodes…
The rel/NF-kB family of transcription factors regulates the activity of genes involved in the immune response, hematopoiesis, and inflammation. NF-kB is…
This gene plays a role in transcriptional regulation and NFKB signal transduction.
